XT
XRTX

XTX Topco’s XORTX Therapeutics XRTX Stock Holding History

XTX Topco’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,764
Closed -$11.2K – 3887
2025
Q3 		$11.2K Buy
+2,764
New +$11.6K ﹤0.01% 2430

Other funds holding XRTX

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

XTX Topco's XRTX Position: Q4 2025 in Review

XTX Topco sold out of XORTX Therapeutics (XRTX) in Q4 2025, closing a stake of 2,764 shares — an estimated $11.2K sold.

XTX Topco first reported a position in XRTX in Q3 2025 and held it in 1 quarter. The position peaked at $11.2K in Q3 2025. 6 funds tracked by Wall St. Rank hold XRTX as of Q4 2025.

  • XTX Topco reported no remaining XORTX Therapeutics position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 2,764 XORTX Therapeutics shares in Q4 2025, an estimated $11.2K.
  • XTX Topco first reported a position in XORTX Therapeutics in Q3 2025 and held it in 1 quarter.
  • XTX Topco's XORTX Therapeutics position peaked at $11.2K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.